| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $168.8M | +2.3% |
| Cost of Revenue | $61.9M | -0.7% |
| Gross Profit | $106.9M | +4.1% |
| R&D Expense | $57.4M | +18.6% |
| SG&A Expense | $45.4M | +15.0% |
| Operating Income | -$56.4M | -72.5% |
| Interest Expense | $2.3M | -22.8% |
| Pre-tax Income | -$60.6M | -14.9% |
| Income Tax | $7.9M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $44.6M | -69.0% |
| Short-term Investments | $41.3M | — |
| Accounts Receivable | $28.8M | +64.4% |
| Current Assets | $133.0M | -24.3% |
| Total Assets | $206.2M | -7.7% |
| Current Liabilities | $108.8M | +11.0% |
| Long-term Debt | $36.0M | -7.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$46.8M | -111.8% |
| Capital Expenditures | $1.2M | -35.1% |
| Investing Cash Flow | -$49.8M | -849.2% |
| Financing Cash Flow | -$529K | -100.4% |
| Free Cash Flow | -$48.0M | -100.3% |
| +19.8% |
| Net Income | -$68.5M | -15.4% |
| EPS (Basic) | -$0.53 | +44.2% |
| Total Liabilities |
| $162.8M |
| +18.0% |
| Stockholders' Equity | $43.3M | -49.2% |